ES-SCLC
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy and Sequential Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer (NCT07349225) | The Second Affiliated Hospital of Dalian Medical University | 2026-01-31 |
Track ES-SCLC automatically
Every clearance here is in the API, with alerts when new ones post.